Characterization of the molecular basis of structural cardiac disease inclu
des elucidating the pathogenesis of certain vascular disease by demonstrati
ng mutations of the Elastin gene as the cause of familial supravalvular aor
tic stenosis (SVAS) and Williams' syndrome (WS). Defining the etiology of S
VAS has clinical implications in terms of prenatal and presymptomatic diagn
osis and possible earlier intervention with medical therapy. This review co
nsiders the evidence relating Elastin mutations to SVAS and WS and outlines
the possible mechanisms by which these mutations give rise to cardiac dise
ase. Finally, the implications which Elastin mutation identification has on
current clinical practice and future research directions are considered.